Results 81 to 90 of about 33,024 (195)

Companion Diagnostics in Clinical Therapy: Current Applications and Future Directions

open access: yesMedComm, Volume 7, Issue 3, March 2026.
Companion diagnostics use biomarker‐based assays to stratify patients for precision therapies, improving outcomes while reducing ineffective treatment and side effects. This review summarizes the evolution, regulatory landscape, clinical applications, and technological platforms of CDx, highlighting their role in biomarker‐driven precision therapy.
Yuesong Wu   +9 more
wiley   +1 more source

Multisystemic tuberculosis with skin involvement in a patient with compromised cellular immunity suggestive of primary immunodeficiency

open access: yesJAAD Case Reports, 2022
Sharely Milagros Loza Canales, MD   +5 more
doaj   +1 more source

Tuberculosis Lymphoedema Cutis

open access: yesIndian Journal of Dermatology, 2001
Lymphoedema following cutaneous tuberculosis is a rare occurrence. A case of elephantiasis of leg following lupus vulgaris is presented. It can still be seen in rural India in untreated advanced cutaneous tuberculosis.
Gangopadhyay Asok Kumar
doaj  

Histological and Immunohistochemical Characterization of a Histiocytic Sarcoma Associated With a Follicular Lymphoma in a Ring‐tailed Lemur (Lemur catta)

open access: yesVeterinary Medicine and Science, Volume 12, Issue 2, March 2026.
Histological and Immunohistochemical Characterization of a Histiocytic Sarcoma Associated with a Follicular Lymphoma in a Ring‐tailed Lemur (Lemur catta). Nicolás Aradilla, Rocío Canales, Teresa Lorenzo‐Bermejo, Mireia Mainez, Jordi Aguiló‐Gisbert, David Marbella, Javier María De Pablo‐Moreno and Antonio Rodríguez‐Bertos.
Nicolás Aradilla   +7 more
wiley   +1 more source

Drug Delivery Systems for Resiquimod to Control Myeloid‐Derived Suppressor Cells in Cancer Immunotherapy

open access: yesWIREs Nanomedicine and Nanobiotechnology, Volume 18, Issue 2, March/April 2026.
Myeloid‐derived suppressor cells (MDSCs) are key contributors to cancer immunotherapy failure and major targets in new therapeutic strategies. We highlight therapeutic approaches to counteract their immunosuppressive functions and discuss recent efforts to optimize drug delivery for controlling MDSCs, focusing on resiquimod as a representative drug ...
Yanying He, Yoon Yeo
wiley   +1 more source

Incidence of various clinico-morphological variants of cutaneous tuberculosis and HIV concurrence: a study from the Indian subcontinent

open access: yesAnnals of Saudi Medicine, 2011
Background and Objectives: There are few reports of cutaneous tuberculosis with immunosuppressed states such as HIV, use of immunosuppressants or malignancy.
Varshney Anupam, Goyal Tarang
doaj  

Atypical rare presentations of cutaneous tuberculosis: A report of two cases

open access: yesClinical Dermatology Review
Cutaneous tuberculosis (TB) is the result of a chronic infection by Mycobacterium TB. The clinical manifestations are variable and depend on the interaction of several factors.
Sahana Srihari   +3 more
doaj   +1 more source

Review of Herpes Zoster Occurrence in Patients With Atopic Dermatitis Treated With JAK Inhibitors

open access: yesClinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT Atopic dermatitis (AD) is a chronic inflammatory skin disease that markedly impairs quality of life. Janus kinase inhibitors (upadacitinib, abrocitinib, and baricitinib) are effective therapies for moderate‐to‐severe AD but are associated with viral reactivation, particularly herpes zoster (HZ), due to immunosuppressive effects on interferon ...
Anna Mandecka   +7 more
wiley   +1 more source

An Asymptomatic Lesion on the Penis

open access: yes
JEADV Clinical Practice, Volume 5, Issue 1, Page 309-311, March 2026.
Brandon Tan   +3 more
wiley   +1 more source

Perianal cutaneous tuberculosis

open access: yesRevista de Gastroenterología de México (English Edition), 2017
G.R. Medina-Murillo   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy